Join the Chronic Migraine group to help and get support from people like you.
Chronic Migraine News (Page 2)
Related terms: Migraine, Chronic
Study Compares Effectiveness of Migraine Preventive Drugs
FRIDAY, Dec. 22, 2023 – For patients with migraine, simvastatin, calcitonin gene-related peptide pathway antibodies (CGRPabs), and amitriptyline have a favorable effect compared with beta blockers,...
Migraine? Reach for Prescription Meds, Not Ibuprofen
THURSDAY, Nov. 30, 2023 – Migraine sufferers would do better to talk to their doctor about a prescription drug than reaching for a bottle of ibuprofen, a new study finds. Drugs like triptans, ergots...
Triptans, Ergots, Antiemetics Most Effective Meds for Migraine
WEDNESDAY, Nov. 29, 2023 – Triptans, ergots, and antiemetics are the most effective classes of medications for migraine, according to a study published online Nov. 29 in Neurology. Chia-Chun Chiang,...
Ubrogepant Beneficial for Treating Migraine During the Prodrome
WEDNESDAY, Nov. 22, 2023 – Ubrogepant is beneficial for the treatment of migraine when taken during the prodrome, according to a study published online Nov. 15 in The Lancet. David W. Dodick, M.D.,...
Adverse Childhood Experiences Linked to Headache in Adulthood
FRIDAY, Oct. 27, 2023 – Adverse childhood experiences (ACEs) are associated with primary headache in adulthood, according to a review published online Oct. 25 in Neurology. Claudia Sikorski, Ph.D.,...
Growing Pains May Be Precursor to Migraine
MONDAY, Sept. 11, 2023 – Growing pains (GP) among children and adolescents may be a precursor to or comorbidity with migraine, according to a study published online Sept. 6 in Headache. Raimundo...
'Magic Mushroom' Drug Psilocybin Shows Early Promise in Easing Migraines
MONDAY, Aug. 14, 2023 – Psilocybin, the active ingredient in "magic" mushrooms, is getting renewed interest as a potential treatment for various health conditions. Now, a new research review argues...
Gadolinium-Enhanced MRI Can Differentiate Meniere From Vestibular Migraine
MONDAY, Aug. 7, 2023 – Gadolinium-enhanced magnetic resonance imaging (MRI) of the inner ear can help differentiate Meniere's disease (MD) from vestibular migraine (VM), according to a study...
Vestibular Function Tests ID Vestibular Migraine Versus Meniere Disease
FRIDAY, July 7, 2023 – Vestibular symptoms and results from vestibular function tests may differentiate between vestibular migraine (VM) and Meniere disease (MD), according to a study published in...
Women With Migraine Have Higher Risk for Heart Attack, Hemorrhagic Stroke
TUESDAY, June 13, 2023 – The risk for ischemic stroke in individuals with migraine is similar for men and women, while the risk for myocardial infarction (MI) and hemorrhagic stroke is only higher...
Intranasal Ketamine Seems Effective for Refractory Chronic Migraine
FRIDAY, June 2, 2023 – Intranasal ketamine seems effective for refractory chronic migraine, with about half of patients reporting it as very effective, according to a study published online May 30...
Ketamine Nasal Spray Could Be New Treatment for Migraines
WEDNESDAY, May 31, 2023 – A nasal spray containing ketamine might help relieve migraine headaches when other treatments fail, a new study suggests. Ketamine is a synthetic anesthetic with...
U.S. FDA Approves Qulipta (atogepant) for Adults With Chronic Migraine
NORTH CHICAGO, Ill., April 17, 2023 /PRNewswire/ – AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has approved expanding the indication of Qulipta (atogepant) ...
Ask a question
To post your own question to this support group, sign in or create an account.